A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

The following is a summary of “Determinants of implementation of continuous glucose monitoring for patients with ...

Digital Health Leader's Innovation in Real-Time Sensor-Based AI Sets New Standards for Personalized Cardiometabolic Care The ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Warning: continuous glucose monitor safety alerts on smart devices, such as smartphones or smartwatches, may not work as expected ...

The overwhelming consensus amongst scientists is that there’s very little evidence to suggest that tracking your blood ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.